Social media users claimed that Vivek Ramaswamy was a con artist who purchased an Alzheimer's drug that had already failed clinical trials four times. Vivek rebranded it, added his mother psychiatrist Geetha Ramaswamy on the board, took the company public through an IPO and cashed out before the drug failed again.